Skip to main content
Egyptian Rheumatology and Rehabilitation
Download PDF

Massive pulmonary embolism in rheumatoid patient treated with raloxifene: a case report

Egyptian Rheumatology and Rehabilitation volume 41, pages 34–36 (2014)Cite this article

Abstract

Introduction

Rheumatoid arthritis (RA) is not generally considered a risk factor for venous thromboembolism.

Case presentation

A patient with RA and postmenopausal osteoporosis was reported with massive pulmonary embolism following treatment with raloxifene for 3 months. This patient met the American College of Rheumatology (ACR) criteria for RA diagnosis in 1988. She was controlled on regular disease modifying antirheumatic drug (DMARDs) for 4 years.

Conclusion

Pulmonary embolism in postmenopausal osteoporotic patient with RA could be due to raloxifene treatment rather than a complication of the disease itself.

References

  1. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315–324.

    Article  CAS  Google Scholar 

  2. Matta F, Singala R, Yaekoub AY, Najjar R, Stein PD. Risk of venous thromboembolism with RA. Thromb Haemost 2009; 101:134–138.

    Article  CAS  Google Scholar 

  3. Niki Y, Mastumoto H, Hakozaki A, Mochizukit T, Momohara S. Rheumatoid arthritis: a risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis. J Orthop Sci 2010; 15:57–63.

    Article  Google Scholar 

  4. Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis 2013; 72:1182–7. doi: 10.1136

    Article  Google Scholar 

  5. Prevoo M, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38:44–48.

    CAS  Google Scholar 

  6. Sewell K, Schein JR. Osteoporosis therapies for RA patients: minimizing gastrointestinal side effects. Semin Arthritis Rheum 2001; 30:288–297.

    Article  CAS  Google Scholar 

  7. Vestergaard P, Schwartz K, Pinholt EM, Rejnmark L, Mosekilde L. Use of bisphosphonate & raloxifene and risk of deep venous thrombosis & pulmonary embolism. Osteoporos Int 2010; 21:1591–1597.

    Article  CAS  Google Scholar 

  8. Adomaityte J, Farooq M, Qayyum R. Effect of raloxifene therapy on venous thromboembolism in postmenopausal women. A meta- analysis. Thromb Haemost 2008; 99:338–342.

    Article  CAS  Google Scholar 

  9. Mosca L, Grady D, Barrett-Connor E, Collins P, Wenger N, Abramson BL et al. Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease. Stroke 2009; 40:147–155.

    Article  CAS  Google Scholar 

  10. De Villiers TJ. Clinical issues regarding cardiovascular disease and selective estrogen receptor modulators in postmenopausal women. Climacteric 2009; 12:108–111.

    Article  CAS  Google Scholar 

  11. Layton D, Clarke A, Wilton LV, Shakir SA. Safety profile of raloxifene as used in general practice in England: results of prescription-event monitoring study. Osteoporos Int. 2005; 16:490–500.

    Article  CAS  Google Scholar 

  12. Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune disease: record linkage study. BMC Med 2011; 9:1.

    Article  Google Scholar 

  13. Yoshitaka T, Abe N, Minaqawa H, Date H, Sakoma Y, Nishida K et al. Disease-specific screening for deep venous thrombosis and pulmonary thromboembolism using plasma D-dimer values after total knee arthroplasty. Mod Rheumatol. 2008; 18:359–365.

    Article  CAS  Google Scholar 

  14. Makol A, Grover M, Guggenheim C, Hassouna H Etanercept and venous thromboembolism: a case series. J Med Case Rep2010; 15:4–12.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Physical Medicine, Rehabilitation and Rheumatology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Hala M. Haider MD

Authors
  1. Hala M. Haider MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hala M. Haider MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Haider, H.M. Massive pulmonary embolism in rheumatoid patient treated with raloxifene: a case report. Egypt Rheumatol Rehabil 41, 34–36 (2014). https://doi.org/10.4103/1110-161X.128134

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-161X.128134

Keywords